The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin

Molecular Carcinogenesis

Volumn 46, Issue 8, 2007, Pages 732-740

  Chebotaev, Dmitry ^a   Yemelyanov, Alexander ^a   Budunova, Irina ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Gene transrepression; Glucocorticoid receptor; Skin carcinogenesis; Stem cells; Tumor suppressor

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; KERATIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; GENE EXPRESSION; GENE REPRESSION; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; EPIDERMIS; HUMANS; RECEPTORS, GLUCOCORTICOID; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 34547883532     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20349     Document Type: Conference Paper

References (38)

1. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev 2003;24:488-522.
2. De Bosscher K, Vanden Berghe W, Haegeman G. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 2006;25:6868-6886.
3. Rogatsky I, Hittelman AB, Pearce D, Garabedian MJ. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Mol Cell Biol 1999;19:5036-5049.
4. Budunova IV, Kowalczyk D, Yao YJ, Perez P, Jorcanom JL, Slaga TJ. Glucocorticoid receptor is the potent suppressor of mouse skin carcinogenesis. Oncogene 2003;22:3279-3287.
5. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002;96:23-43.
6. Beato M, Herrlich P, Schultz G. Steroid hormone receptors: Many actors in search of a plot. Cell 1995;83:851-857.
7. Yudt MR, Cidlowski JA. The glucocorticoid receptor: Coding a diversity of proteins and responses through a single gene. Mol Endocrinol 2002;16:1719-1726.
8. Schacke H, Rehwinkel H, Asadullah K, Cato AC. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp Dermatol 2006;15:565-573.
9. Budunova IV, Kang H, Carbajal S, Viaje A, Slaga TJ. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Mol Carcinog 1997;18:177-185.
10. Yemelyanov A, Czwornog J, Chebotaev D, et al. Tumor suppressor effect of glucocorticoid receptor in prostate. Oncogene 2007; 26: 1885-1896.
11. Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 2004; 1:239-246.
12. Greenstein S, Ghias K, Krett NL, Rosen ST. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 2002;8:1681-1694.
13. Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res 2006;12:3003-3009.
14. Nishimura K, Nonomura N, Satoh E, et al. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst 2000;93:1739-1746.
15. Crowley P, Lai NY, De Young N, Pearce P, Funder JW, Gill PG. Inhibition of growth of B16 melanoma by glucocorticoids does not result directly from receptor-mediated inhibition of tumour cells. Oncology 1988;45:331-335.
16. Schiffelers RM, Metselaar JM, Fens MH, Janssen AP, Molema /SNM〉 G, Storm G. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia 2005;7:118-127.
17. Osman AM, Jansen PW, Smets LA, Benckhuijsen C. Glucocorticoid receptorsand cell cycle progression in human melanoma cell lines. J.Cell Physiol 1985;125:306-312.
18. Karlan BY, Amin W, Casper SE, Littlefield BA. Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: Inhibition by glucocorticoids. Cancer Res 1988;48:3502-3506.
19. Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I. The tumor suppressor effect of glucocorticoid receptor in skin is mediated via its effect on follicular stem cells. Oncogene 2006; [Epub ahead of print].
20. Yao R, Wang Y, Lemon WJ, Lubet RA, You M. Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions. Oncogene 2004;23:7746-7752.
21. Ouatas T, Halverson D, Steeg PS. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: New uses for old compounds. Clin Cancer Res 2003;9:3763-3772.
22. Shiratsuchi T, Ishibashi H, Shirasuna K. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. J Cell Physiol 2002;193:340-348.
23. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-545.
24. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
25. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-436.
26. Karin M, Gallagher E. From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005;57:283-295.
27. Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002;296:1634-1635.
28. Slaga TJ, DiGiovanni J, Winberg LD, Budunova IV. Skin carcinogenesis: Characteristics, mechanisms, and prevention. Prog Clin Biol Res 1995;391:1-20.
29. Spiegelman VS, Budunova IV, Carbajal S, SlagaTJ. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids. Mol Carcinog 1997;20:99-107.
30. Perez P, Page A, del Rio M, et al. The proliferative and inflammatory responses are impaired in the skin of transgenic mice overexpressing the glucocorticoid receptor. FASEB J 2001;11:2030-2032.
31. Morris RJ. A perspective on keratinocyte stem cells as targets for skin carcinogenesis. Differentiation 2004;72:381-386.
32. Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003;3:444-451.
33. Lavker RM, Sun TT. Epidermal stem cells: Properties, markers, and location. Proc Natl Acad Sci USA 2000;97:13473-13475.
34. Morris RJ, Liu Y, Maries L, et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004;22:411-417.
35. Tumbar T, Guasch G, Greco V, et al. Defining the epithelial stem cell niche in skin. Science 2004;303:359-363.
36. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006;22:339-373.
37. Ghazizadeh S, Taichman LB, Multiple classes of stem cells in cutaneous epithelium: A lineage analysis of adult mouses kin. EMBO J 2001;20:1215-1222.
38. Inze D. Green light for the cell cycle. EMBO J 2005;24:657-662.